Literature DB >> 8640352

Pharmacological evidence for a single bradykinin B2 receptor in the guinea-pig.

D Pruneau1, J M Luccarini, E Defrêne, J L Paquet, P Bélichard.   

Abstract

1. The present study addresses the possibility of the existence of different kinin B2 receptor subtypes in the guinea-pig by evaluating the affinity of peptide and nonpeptide receptor antagonists. For this purpose, jugular vein rings, ileum segments, lung parenchymal and trachea strips were set up in organ baths for isometric tension measurements. The experiments were conducted in the presence o indomethacin (3 microM), atropine (10 microM) and captopril (10 microM). 2. BK contracted jugular vein (JV), ileum (GPI), parenchyma (LP) and trachea (GPT) with an EC50 of 13.2 +/- 1.4 nM (n=27), 11.2 +/- 2.1 (n=26), 23.6 +/- 6.3 (n=26), and 33.0 +/- 6.5 (n=27), respectively. Thiorphan, a neutral endopeptidase (EC 3.4.34.11) inhibitor and MERGETPA (DL-2-mercaptomethyl-3-guanidinoethylthiopropanoic acid), a carboxypeptidase inhibitor, had no effect on the BK-induced contractions of JV, GPI and LP. In the GPT, thiorpan potentiated the contractile response to BK and was thus added in the corresponding experiments. 3. The peptide B2 receptor antagonist, Hoe 140 and the nonpeptide compound, WIN 64338, behaved as noncompetitive antagonists against contractile responses to cumulative BK in the four tissues although Hoe 140 appeared as a competitive inhibitor in the GPT only. IN order to compare the inhibitory potency of these compounds between tissues, pKB values were determined. Mean values of pKB for Hoe 140 were 8.05 +/- 0.07, 8.43 +/- 0.11, 8.13 +/- 0.18, and 8.52 +/- 0. 25 in the JV, GPI, GPT and LP, respectively. WIN 64338 gave mean pKB values of 6.89 +/- 0.10, 7.57 +/- 0.12, 7.36 +/- 0.12 adn 7.51 +/- 0.28 in the JV, GPI, LP and GPT, respectively. 4. D-Arg [Hyp3, D-Phe7, Leu8]BK and D-Arg[Hyp3, D-Phe7]BK (NPC 567) inhibited in a competitive fashion the concentration-response curves to BK. Values of pA2for each compound were not significantly different in the four tissues and were between 5.81 and 6.31 for D-Arg [Hyp3, D-Phe7, Leu8]BK and between 5.55 and 5.65 for NPC 567.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8640352      PMCID: PMC1908926          DOI: 10.1111/j.1476-5381.1995.tb16418.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Spinal noradrenergic pathways and pressor responses to central angiotensin II.

Authors:  J L Elghozi; G A Head
Journal:  Am J Physiol       Date:  1990-01

2.  Characterization of kinin receptors by bioassays.

Authors:  F Gobeil; D Regoli
Journal:  Braz J Med Biol Res       Date:  1994-08       Impact factor: 2.590

Review 3.  Pharmacology of bradykinin and related kinins.

Authors:  D Regoli; J Barabé
Journal:  Pharmacol Rev       Date:  1980-03       Impact factor: 25.468

4.  Arachidonic acid metabolites and airway epithelium-dependent relaxant factor.

Authors:  E Tschirhart; N Frossard; C Bertrand; Y Landry
Journal:  J Pharmacol Exp Ther       Date:  1987-10       Impact factor: 4.030

5.  Expression cloning of a rat B2 bradykinin receptor.

Authors:  A E McEachern; E R Shelton; S Bhakta; R Obernolte; C Bach; P Zuppan; J Fujisaki; R W Aldrich; K Jarnagin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

6.  Effect of bradykinin on opossum esophageal longitudinal smooth muscle: evidence for novel bradykinin receptors.

Authors:  J K Saha; J N Sengupta; R K Goyal
Journal:  J Pharmacol Exp Ther       Date:  1990-03       Impact factor: 4.030

7.  Evidence for a pulmonary B3 bradykinin receptor.

Authors:  S G Farmer; R M Burch; S A Meeker; D E Wilkins
Journal:  Mol Pharmacol       Date:  1989-07       Impact factor: 4.436

8.  Evidence for two high-affinity bradykinin binding sites in the guinea-pig lung.

Authors:  A Trifilieff; E B Haddad; Y Landry; J P Gies
Journal:  Eur J Pharmacol       Date:  1991-06-19       Impact factor: 4.432

9.  Effects of bradykinin and bradykinin analogs on the opossum lower esophageal sphincter: characterization of an inhibitory bradykinin receptor.

Authors:  J K Saha; J N Sengupta; R K Goyal
Journal:  J Pharmacol Exp Ther       Date:  1991-10       Impact factor: 4.030

10.  The competitive antagonistic effect of compounds from Mandevilla velutina on kinin-induced contractions of rat uterus and guinea-pig ileum in vitro.

Authors:  J B Calixto; M G Pizzolatti; R A Yunes
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

View more
  5 in total

1.  Actions of bradykinin on electrical and synaptic behavior of neurones in the myenteric plexus of guinea-pig small intestine.

Authors:  Hong-Zhen Hu; Sumei Liu; Na Gao; Yun Xia; Randa Mostafa; Jun Ren; Dimiter H Zafirov; Jackie D Wood
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

2.  Pharmacological and functional characterization of the guinea-pig B2 bradykinin receptor stably expressed in CHO-K1 cell line.

Authors:  C Robert; D Pruneau; J-L Paquet
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

3.  Characterization of the bradykinin receptor in the human nasal airway using the binding of [125I]-Hoe 140.

Authors:  J W Dear; K Wirth; G K Scadding; J C Foreman
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

4.  Bradykinin increases Na(+)-K(+) pump activity in cultured guinea-pig tracheal smooth muscle cells.

Authors:  A M Dodson; K J Rhoden
Journal:  Br J Pharmacol       Date:  2001-08       Impact factor: 8.739

5.  Haemodynamic and cardiac effects of kinin B1 and B2 receptor stimulation in conscious instrumented dogs.

Authors:  P Bélichard; B Loillier; J L Paquet; J M Luccarini; D Pruneau
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.